LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

Search

NeoGenomics Inc

Suletud

7.41 4.07

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

7.11

Max

7.42

Põhinäitajad

By Trading Economics

Sissetulek

-11M

-26M

Müük

-4M

168M

Aktsiakasum

-0.204

Kasumimarginaal

-15.427

Töötajad

2,200

EBITDA

-10M

-6.3M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+84.99% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

28. juuli 2025

Turustatistika

By TradingEconomics

Turukapital

-360M

923M

Eelmine avamishind

3.34

Eelmine sulgemishind

7.41

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bearish Evidence

NeoGenomics Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

4. juuni 2025, 14:53 UTC

Suurimad hinnamuutused turgudel

BitFuFu Shares Climb on Surge in Bitcoin Production

4. juuni 2025, 14:40 UTC

Suurimad hinnamuutused turgudel

K Wave Media Shares Triple on Bitcoin Treasury Stock Sale

30. mai 2025, 08:17 UTC

Peamised uudised

Global Markets Mixed Amid Tariff Uncertainty; PCE Inflation Data Eyed

6. juuni 2025, 14:28 UTC

Market Talk

Bitcoin Rises After Above-Forecast U.S. Jobs Data -- Market Talk

4. juuni 2025, 21:26 UTC

Omandamised, ülevõtmised, äriostud

New MicroStrategy Preferred, a Bitcoin Play, Should Yield 10% or More -- Barrons.com

4. juuni 2025, 11:24 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

4. juuni 2025, 11:24 UTC

Market Talk

Bitcoin ETFs See Outflows -- Market Talk

4. juuni 2025, 09:58 UTC

Market Talk

Bitcoin Eases but Remains Attractive Amid Muted Volatility -- Market Talk

4. juuni 2025, 09:58 UTC

Market Talk

Global Equities Roundup: Market Talk

3. juuni 2025, 10:28 UTC

Market Talk

Bitcoin Rises, Recovering After Recent Falls -- Market Talk

2. juuni 2025, 11:33 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

2. juuni 2025, 11:33 UTC

Market Talk

Bitcoin Falls as Trade Tensions Cause Risk Aversion -- Market Talk

30. mai 2025, 16:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

30. mai 2025, 13:43 UTC

Market Talk

Trump's Immigration Clampdown a Possible Headwind to Digital Assets -- Market Talk

30. mai 2025, 13:43 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

30. mai 2025, 07:18 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

30. mai 2025, 07:18 UTC

Market Talk

Bitcoin Falls on Renewed Tariff Concerns -- Market Talk

29. mai 2025, 07:00 UTC

Market Talk
Tulu

Bitcoin Rises After Upbeat Nvidia Earnings, Tariff Ruling -- Market Talk

28. mai 2025, 08:21 UTC

Market Talk

Bitcoin Falls Ahead of Nvidia Earnings, Fed Minutes -- Market Talk

27. mai 2025, 20:21 UTC

Peamised uudised

Trump's Media Company to Raise $2.5 Billion to Buy Bitcoin -- 2nd Update

27. mai 2025, 15:44 UTC

Peamised uudised

Trump's Media Company to Raise $2.5 Billion to Buy Bitcoin -- Update

27. mai 2025, 15:36 UTC

Peamised uudised

Trump's Media Company to Raise $2.5 Billion to Buy Bitcoin -- Update

27. mai 2025, 14:44 UTC

Tulu
Omandamised, ülevõtmised, äriostud

DJT Stock Falls. The Truth Social Parent Is Raising $2.5 Billion to Buy Bitcoin. -- Barrons.com

27. mai 2025, 08:49 UTC

Market Talk

Bitcoin Falls as Trade Uncertainty Dampens Risk Appetite -- Market Talk

26. mai 2025, 09:57 UTC

Market Talk

Bitcoin Rises as U.S. Delay of Big EU Tariffs Supports Risk Appetite -- Market Talk

23. mai 2025, 18:52 UTC

Omandamised, ülevõtmised, äriostud

DDC Enterprise Issues 254,333 Class A Ordinary Shrs in Exchange for 21 BTC, Valued at About $2.28M in Current Market Price

23. mai 2025, 12:51 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

23. mai 2025, 12:51 UTC

Market Talk

Bitcoin Falls as Trump's EU Tariff Threat Dents Risk Appetite -- Market Talk

23. mai 2025, 07:31 UTC

Market Talk

Bitcoin Eases Slightly After Reaching Fresh Record High -- Market Talk

23. mai 2025, 03:16 UTC

Peamised uudised

Big Banks Explore Venturing Into Crypto World Together With Joint Stablecoin -- WSJ

Võrdlus sarnastega

Hinnamuutus

NeoGenomics Inc Prognoos

Hinnasiht

By TipRanks

84.99% tõus

12 kuu keskmine prognoos

Keskmine 13.19 USD  84.99%

Kõrge 26 USD

Madal 8.5 USD

Põhineb 12 Wall Streeti analüütiku instrumendi NeoGenomics Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

12 ratings

7

Osta

5

Hoia

0

Müü

Tehniline skoor

By Trading Central

7.7 / 10.27Toetus ja vastupanu

Lühikene perspektiiv

Very Strong Bearish Evidence

Keskpikk perspektiiv

Bearish Evidence

Pikk perspektiiv

Bearish Evidence

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.